This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This election year, Capitol Hill buzzed with discussions about cannabis scheduling, hemp regulations, and the FDA’s evolving role in regulating cannabinoids. Yet, missing from these debates was one critical topic: the future of medical cannabis and protections for patients.
The new law defines cannabinoid edible products" as soft or hard lozenges in a geometric square shape into which a cannabinoid concentrate or the dried leaves or flowers of the plant of the genus cannabis is incorporated.
Consider it a testament to the ubiquity and flexibility of the endocannabinoid system: we can inhale medicinal cannabinoids via combustion or vaporization; ingest them via food or drink; and absorb them directly through the skin, the bodys largest organ. This latter category is broader and more complex than many of us give it credit for.
But pioneer cannabis clinician Bonni Goldstein, MD, cautions patients and physicians not to overstate the findings of the new FDA study, which was published in JAMA Internal Medicine. In fact, the majority of people that seek my advice about CBD are underdosing. In all cases, labs normalized after CBD dosing was reduced or discontinued.
In short, the complaint is that the defendants negligently failed to warn consumers, patients and their treating professionals of the risk of developing cannabis hyperemesis syndrome (CHS). What exactly is cannabinoid hyperemesis syndrome? Below are some thoughts in Q&A format. What does the Canadian lawsuit claim?
The post Understanding Cannabis Use Disorder: Causes, Symptoms, and Treatment appeared first on United Patients Group. Early intervention can prevent the long-term consequences of Cannabis Use Disorder and support a healthier, balanced lifestyle.
Whether we’re advocating for end-of-life dignity, cannabinoid therapies, or affirming care for queer youth, hope becomes activism when it is shared aloud. Milk’s legacy lives on every time a nurse, patient, or healer dares to say, “We deserve better”—and works to make it so. Milk Foundation). Her motto? “I
Whether you’re a medical professional, a patient, or just someone interested in natural wellness, understanding how CBD and THC differ can seriously change how you think about healing. Understanding Cannabinoids: The Basics of CBD and THC Cannabinoids, CBD, THC—chances are you’ve heard these terms buzzing around lately, and for good reason!
Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.”
Miami’s Approach: Personalized Care at LifeCannMD At LifeCannMD in Miami, Dr. Fernando Fandio-Sende is allowed to provide recommendations for a Medical Marijuana Card for patients with OCD as long as they have one of Floridas qualifying conditions for medical marijuana treatment.
A mind-blowing study from 2024 showed that more than 70% of patients using medical marijuana saw major improvements in managing chronic conditions. Some patients even say that using medical marijuana helps them feel more “normal” and less trapped by their condition. Medical marijuana is totally shaking up the healthcare scene!
Here’s something that blows most of my patients’ minds: your body actually has built-in receptors for cannabis compounds. I’ve guided hundreds of patients through this process, and honestly? Great News for Seizure Patients If you’ve got epilepsy or any seizure disorder, you’re already qualified.
It is sought after because it contains all the cannabinoids (the highest concentrate of THC), terpenes, and other compounds found in the cannabis plant. Most patients say it tastes terrible – imagine the most bitter, plant-like flavor you can think of, and you’re getting close. And he never turned anyone away.
Cannabis Caregiver Not to be confused with a cannabis healthcare provider, a cannabis coach , or a cannabis consultant , a cannabis caregiver is a representative designated to assist individual medical marijuana patients who cannot procure or apply cannabis treatments for themselves. Marijuana or Cannabis?
Cannabis, with its cannabinoids, can tap into this system, helping to create a more relaxed, balanced state. So, be patient! Important Cannabinoid Profiles Okay, so cannabinoids are the compounds in cannabis that are responsible for its effects. It controls things like mood, stress, and even sleep. And the best part?
These patients and their stories raise urgent questions about the UK’s medical cannabis system: Why must so many severely ill individuals break the law to access medicine? And how are patients weighing the risks and benefits of illicit cannabis in the absence of affordable, legal alternatives?
Medical cannabis patients are under threat again. For over a decade, the CJS Amendment has protected patients and caregivers from federal interference. Patients deserve certainty, not another decade of temporary fixes. Federal Medical Cannabis Protections are at Risk, Again! Reach out to your federal representatives today!
Despite common misconceptions, 420 is not a police code, Bob Marley’s birthday (he was born on February 6), or the total number of active cannabinoids in the cannabis plant—though the latter is an amusing coincidence. Many believe that 420 originated as a police radio code for marijuana violations, but this widespread myth is far from true.
By incorporating cannabinoids, we can explore their potential as powerful tools for promoting health, wellness, and healing, paving the way for a stronger, healthier future. With growing awareness around the globe, cannabinoids such as CBD, CBG, and CBN are gaining recognition for their potential benefits. 2017; Sultan et al.,
At a time when cannabis was still whispered about, we were building trust with patients, advocating for access, and learning what truly helps people feel better – and that’s still our mission today. That’s why our Mesa dispensary remains a staple for both longtime medical patients and new recreational users.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. New: This report is now available in Spanish and Japanese translations! See bottom of this article for downloads.
“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.".
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.
“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report, summarized below, is available for free download at the bottom of the page.
The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus. And its conclusion?
Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Americans for Safe Access (ASA) fully supports the regulation of cannabinoid products as part of our mission to ensure safe access for patients, and we want you to be successful in your efforts to do so in California. Unfortunately, our efforts to alter the legislation to protect these patients failed, and so did AB 2223.
.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
“When it comes to addressing questions specific to the safety and therapeutic efficacy of cannabis, this publication provides the evidence that patients and their physicians – as well as lawmakers – need to know.”.
Patients require potent pain medication afterwards, often for extended periods. Some years ago, a woman named Jo Cameron had hip surgery but responded in a strange way: she reported a lack of […] The post Cannabinoids, pain, anxiety & fear: The biology of negative emotion appeared first on Leafly.
Published in Nature Partner Journals and sponsored by the Parkinson’s Foundation, the study found that nearly 25% of Parkinson’s patients had used cannabis in the past six months, but that one in four of that group did not know what type or form of cannabis they used, and nearly half did not know their dosage. Of the 43.9% Altogether, 24.5%
Historical sources show that people as early as 300 BCE were aware of cannabis’ appetite-stimulating effects —particularly for sweet and savory food—but who’d have thought that worms (that’s right, worms) also get a case of “the munchies” after being exposed to cannabinoids?
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Cannabinoid crystals.
In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms. Findings from another recent survey of New York and Minnesota medical cannabis dispensary patients were similar.
However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content